Basic Information
LncRNA/CircRNA Name | LINC-ROR |
Synonyms | LINC-ROR, ROR, lincRNA-RoR |
Region | GRCh38_18:57054558-57072119 |
Ensemble | ENSG00000258609 |
Refseq | NR_048536 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | 2 | ||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | anaplastic thyroid cancer |
ICD-0-3 | C73 |
Methods | qPCR, other |
Sample | anaplastic thyroid cancer cell lines (TPC-1 and THJ-16T) |
Expression Pattern | up-regulated |
Function Description | Additionally, the cells were examined for lncRNA expression after 6 days of treatment by RT-qPCR revealing a significant upregulation in 3 lncRNAs(MALAT1, PVT1 and linc-ROR) studied. The EMT exosomes transferred the lncRNA MALAT1 and EMT effectors SLUG and SOX2; however, EMT was not induced in this model. The exosomes from the CSC model also transferred the lncRNA MALAT1 and the transcription factors SLUG and SOX2 but additionally transferred linc-ROR and induced EMT in the normal thyroid cells. Preliminary siRNA studies directed towards linc-ROR reduced invasion. We hypothesize that CSC exosomes transfer lncRNAs, importantly linc-ROR, to induce EMT and inculcate the local tumor microenvironment and the distant metastatic niche. Therapies directed towards CSCs, their exosomes and/or the lncRNAs they carry may reduce a tumor's metastatic capacity. |
Pubmed ID | 29967342 |
Year | 2018 |
Title | Thyroid Cancer Stem-Like Cell Exosomes: Regulation of EMT via Transfer of lncRNAs |
External Links
Links for LINC-ROR | GenBank HGNC NONCODE |
Links for anaplastic thyroid cancer | OMIM COSMIC |